Colgate-Palmolive (CL) Plans Quarterly Dividend of $0.42

Colgate-Palmolive (NYSE:CL) declared a quarterly dividend on Thursday, January 10th, RTT News reports. Shareholders of record on Wednesday, January 23rd will be given a dividend of 0.42 per share on Friday, February 15th. This represents a $1.68 dividend on an annualized basis and a yield of 2.72%.

Colgate-Palmolive has increased its dividend by an average of 3.4% annually over the last three years and has increased its dividend annually for the last 55 consecutive years. Colgate-Palmolive has a dividend payout ratio of 55.6% meaning its dividend is sufficiently covered by earnings. Research analysts expect Colgate-Palmolive to earn $3.03 per share next year, which means the company should continue to be able to cover its $1.68 annual dividend with an expected future payout ratio of 55.4%.

NYSE:CL opened at $61.82 on Friday. The company has a market cap of $53.17 billion, a PE ratio of 21.54, a PEG ratio of 2.94 and a beta of 0.75. Colgate-Palmolive has a 1-year low of $57.41 and a 1-year high of $77.91.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, October 26th. The company reported $0.72 earnings per share for the quarter, meeting the consensus estimate of $0.72. The firm had revenue of $3.85 billion during the quarter, compared to analyst estimates of $3.89 billion. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The business’s quarterly revenue was down 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.73 EPS. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 2.96 earnings per share for the current year.

Several equities analysts have recently weighed in on CL shares. Goldman Sachs Group raised shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a report on Tuesday. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Friday, October 5th. Morgan Stanley cut their price target on shares of Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating for the company in a report on Tuesday, October 30th. JPMorgan Chase & Co. lowered shares of Colgate-Palmolive from a “neutral” rating to an “underweight” rating and cut their price target for the stock from $61.00 to $54.00 in a report on Monday, October 29th. Finally, Wells Fargo & Co cut their price target on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating for the company in a report on Wednesday, October 17th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $67.71.

ILLEGAL ACTIVITY NOTICE: This report was first published by Dakota Financial News and is the property of of Dakota Financial News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Read More: Trading signals using Bollinger bands

Dividend History for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with's FREE daily email newsletter.

Leave a Reply